Michaela Bowden received her Ph.D. from Dublin City University in Ireland and went on to complete a Post-Doctoral Research Fellowship at Tufts University. She then spent 4years as a Research Fellow at Novartis Institutes for Biomedical Research, Inc, in Cambridge MA. Dr. Bowden has a strong interdisciplinary skill set with an emphasis on biomarker discovery utilizing cellular and molecular biology techniques. She has previously worked on identifying and evaluating candidate oncogenic biomarkers of small molecule inhibition with a view to elucidating the underlying mechanism of action through analysis of the associated signaling pathways. Dr. Bowden is very interested in molecular characterization of potential prognostic biomarkers of prostate cancer and in developing the molecular approach to utilizing archival FFPE prostate cancer tissues most efficiently.